
Source: www.aidsmeds.com
The U.S. Food and Drug Administration has approved the entry inhibitor Selzentry (maraviroc) for people just starting antiretroviral (ARV) therapy for the first time, according to an announcement by the drug’s maker, ViiV Healthcare.

AIDSmeds.com
POZ Fact Sheets – printable/downloadable
one-page topical reference sheets on an ever expanding group of HIV/AIDS topics including: Access to care, adherence, aging, exercise, family planning, heart health, labwork, lipids, lipoatrophy, liver health, nutrition, prevention, skin health, starting treatment, whole health AND more...
Source: www.poz.com
POZ chronicles the HIV epidemic, both in the States and overseas. Supports AIDS healthcare providers and empowers patients through publications, seminars and educational programs.

AIDSmeds.com AIDSmeds most popular lesson an introduction to Herpes (shingles). What is it? What are symptoms? How is it diagnosed? How is it treated? How is it prevented? It's all here.
Source: www.aidsmeds.com
AIDSmeds.com is dedicated to providing people living with HIV the necessary information they need to make empowered treatment decisions. By offering complete, but not complicated, up-to-date HIV and AIDS ...

Plwha TravelwithHiv List of HIV travel restrictions and retreats: www.plwha.org
Source: www.plwha.org
Planing a trip? Visiting family? Looking to emigrate? Click on this map for HIV travel restrictions, it could save you a wasted journey.

Source: www.aidsmeds.com
Some disturbing news for treatment-experienced patients holding out for Myriad Genetics’ maturation inhibitor bevirimat: According to a study published online November 18 in AIDS, resistance to protease inhibitors (PIs) reduces the effectiveness of bevirimat in up to 45 percent of cases.

AIDSmeds.com Get your AIDSmeds Treatment news widget for Facebook, Blogger, MySpace and Twitter!
Source: www.widgetbox.com
Get the AIDSmeds Treatment News widget on Widgetbox.com! AIDSmeds.com is dedicated to providing people living with HIV the necessary information they need to make empowered treatment decisions. By offering complete, but not complicated, up-to-date HIV and AIDS treatment and care information,...

Scott this site has a wealth of information. Most anything you ever wanted or need to know is here.

Source: www.aidsmeds.com
People with low CD4 cells might be more likely to have signs of accelerated aging of their blood vessels, according to a study published in the December 1 issue of Clinical Infectious Diseases.

Zack
Anyone in Pennsylvania? We are the largest HIV/AIDS organization in the state
Join up!

Source: www.aidsmeds.com
A hepatitis C virus (HCV) therapeutic vaccine—designed to boost immune control of the virus in people already infected with HCV—has demonstrated that such an approach might work, according to a study presented at the American Association for the Study of Liver Disease (AASLD) Conference in Boston, a...

AIDSmeds.com - Top Stories : Early Treatment, Non-AIDS Disease Management Stressed in New European G
Source: www.aidsmeds.com
Antiretroviral (ARV) therapy is now recommended for certain people living with HIV with CD4 counts between 350 and 500 cells, according to new HIV treatment guidelines released this week by the European AIDS Clinical Society (EACS). The revised recommendations, which hint at similar changes to U.S. ...

Source: www.aidsmeds.com
Rates of chlamydia, gonorrhea and syphilis remain at high levels in the United States—particularly among teens—according to new data from the Centers for Disease Control and Prevention (CDC), reported on by Reuters. All three of these sexually transmitted infections (STIs) increase the risk of HIV t...

Source: www.aidsmeds.com
A new study adds to the evidence that vitamin D deficiency is common in people living with HIV. The new data, from an Italian study reported last week at the 12th European AIDS Conference in Cologne, Germany, and summarized by the National AIDS Treatment Advocacy Project (NATAP), underscore the pote...

Source: www.aidsmeds.com
A therapeutic vaccine designed to help the immune system better control human papillomavirus (HPV) was nearly 50 percent effective in eliminating precancerous genital lesions, according to a study published November 5 in The New England Journal of Medicine. These encouraging data raise hopes for tre...

Source: www.aidsmeds.com
People with higher HIV levels are more likely to have a cluster of symptoms—called metabolic syndrome—associated with cardiovascular disease than people with lower viral loads, according to a study published in the December issue of the Journal of Acquired Immune Deficiency Syndromes.

















